Nurix Therapeutics Inc (NRIX)
$26.80 -1.18% Close Oct 30, 2026 Live
Nurix Therapeutics stock today
Nurix Therapeutics closed at $26.80 on October 30, 2026, down 1.18% on the day. Over the past year it returned +109.7% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $2.78 billion.
$15.00$20.00$25.00
NovJan 2026MarMayJulSep
| Period | NRIX | S&P 500 (SPY) |
|---|---|---|
| 1 month | +13.0% | -0.9% |
| 3 months | +13.7% | +2.1% |
| Year to date | +41.3% | +11.7% |
| 1 year | +109.7% | +12.4% |
| 3 years | +409.5% | +88.5% |
| 5 years | -19.9% | +76.0% |
Key statistics
- Market value
- $2.78B
- P/E (trailing)
- 11.7
- Price / sales
- 4.0
- 52-week range
- $12.17 to $27.79
About Nurix Therapeutics
Nurix Therapeutics develops protein degradation-based therapeutics for cancer and immune diseases.
Sector: Health Care
More on Nurix Therapeutics
- Financials: revenue, earnings and segmentsRevenue +54% in the year to Nov 2025
- Valuation: P/E history and peersP/E 11.7
- Returns: what $1,000 became$1,000 five years ago is $801.20 today
No forecast, no recommendation. This page describes Nurix Therapeutics Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.